Recent 8-K filings for IMNM

Each filing is summarized by an LLM — headline, three bullets, event type. The source document on EDGAR is one click away. See methodology.

• May 12, 2026 20:05 UTC earnings item 2.02item 9.01

  Immunome Q1 2026 net loss $53.8M; NDA filed for varegacestat; cash $582.7M

source · IMNM on sec.gov